214 related articles for article (PubMed ID: 32431489)
1. Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome.
Zhou QB; Liu ZT; Wang HZ; Guo XQ; Xu YG; Hu XM
Drug Des Devel Ther; 2020; 14():1641-1650. PubMed ID: 32431489
[TBL] [Abstract][Full Text] [Related]
2. Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines.
Hu XM; Yuan B; Tanaka S; Song MM; Onda K; Tohyama K; Zhou AX; Toyoda H; Hirano T
Hematology; 2014 Sep; 19(6):352-60. PubMed ID: 24192507
[TBL] [Abstract][Full Text] [Related]
3. Effects of arsenic disulfide on apoptosis, histone acetylation, toll like receptor 2 activation, and erythropoiesis in bone marrow mononuclear cells of myelodysplastic syndromes patients in vitro.
Xu M; Ren JY; Guo YC; Xu BX; Zeng Q; Hu Q; Zhou YM; Lu JH
Leuk Res; 2017 Nov; 62():4-11. PubMed ID: 28963909
[TBL] [Abstract][Full Text] [Related]
4. Intragenic hypomethylation of DNMT3A in patients with myelodysplastic syndrome.
Zhang YY; Zhou JD; Yang DQ; He PF; Yao DM; Qian Z; Yang J; Xu WR; Lin J; Qian J
Clin Chem Lab Med; 2018 Feb; 56(3):485-491. PubMed ID: 29031013
[TBL] [Abstract][Full Text] [Related]
5. Arsenic disulfide induced apoptosis and concurrently promoted erythroid differentiation in cytokine-dependent myelodysplastic syndrome-progressed leukemia cell line F-36p with complex karyotype including monosomy 7.
Hu XM; Tanaka S; Onda K; Yuan B; Toyoda H; Ma R; Liu F; Hirano T
Chin J Integr Med; 2014 May; 20(5):387-93. PubMed ID: 24610410
[TBL] [Abstract][Full Text] [Related]
6. Clinical Response to Traditional Chinese Herbs Containing Realgar (As
Zhou QB; Du Y; Zhang SS; Liu ZT; Ma R; Xu YG
Cancer Manag Res; 2021; 13():55-63. PubMed ID: 33442294
[TBL] [Abstract][Full Text] [Related]
7. Expression Profiles of DNA Methylation and Demethylation Machinery Components in Pediatric Myelodysplastic Syndrome: Clinical Implications.
Lamim Lovatel V; de Souza Fernandez C; Ferreira Rodrigues E; de Cassia Tavares R; Sobral da Costa E; Abdelhay E; Coelho Soares Lima S; de Souza Fernandez T
Cancer Manag Res; 2020; 12():543-556. PubMed ID: 32158259
[TBL] [Abstract][Full Text] [Related]
8. Role of heme oxygenase-1 in demethylating effects on SKM-1 cells induced by decitabine.
Gao R; Ma D; Wang P; Sun J; Wang JS; Fang Q
Genet Mol Res; 2015 Dec; 14(4):17788-98. PubMed ID: 26782424
[TBL] [Abstract][Full Text] [Related]
9. [Apoptosis of in vitro cultured BMMNC from MDS patients induced by arsenic sulfide].
Yuan HJ; Xu RR; Ding RS; Jiang SH; Lu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):276-80. PubMed ID: 16638196
[TBL] [Abstract][Full Text] [Related]
10. [Effects of uroacitides on the methylation of PTEN gene in myelodysplastic syndrome cells and its mechanism].
Huang J; Yang M; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2013 Jul; 34(7):600-5. PubMed ID: 23906454
[TBL] [Abstract][Full Text] [Related]
11. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.
Walter MJ; Ding L; Shen D; Shao J; Grillot M; McLellan M; Fulton R; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Kandoth C; Baty J; Westervelt P; DiPersio JF; Mardis ER; Wilson RK; Ley TJ; Graubert TA
Leukemia; 2011 Jul; 25(7):1153-8. PubMed ID: 21415852
[TBL] [Abstract][Full Text] [Related]
12. Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer.
He S; Wang F; Yang L; Guo C; Wan R; Ke A; Xu L; Hu G; Xu X; Shen J; Wang X
PLoS One; 2011; 6(11):e27684. PubMed ID: 22110720
[TBL] [Abstract][Full Text] [Related]
13. Traditional Chinese Medicine Containing Arsenic Treated MDS Patients Effectively through Regulating Aberrant Hypomethylation.
Zhou QB; Zhu QZ; Wang HZ; Wang DX; Liu ZT; Xu YG; Hu XM; Ma R; Xu FQ
Evid Based Complement Alternat Med; 2020; 2020():7469809. PubMed ID: 32215045
[TBL] [Abstract][Full Text] [Related]
14. Realgar (α-As
Zhang M; Zhang JY; Sun MQ; Lu P; Liu JX
Chin J Integr Med; 2022 Mar; 28(3):281-288. PubMed ID: 32418175
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.
Rajendran G; Shanmuganandam K; Bendre A; Muzumdar D; Goel A; Shiras A
J Neurooncol; 2011 Sep; 104(2):483-94. PubMed ID: 21229291
[TBL] [Abstract][Full Text] [Related]
16. Methyltransferases in myelodysplastic syndromes: guilty or not guilty?
Quesnel B
Leuk Res; 2009 May; 33(5):601-2. PubMed ID: 19070898
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional control of the DNA methyltransferases is altered in aging and neoplastically-transformed human fibroblasts.
Casillas MA; Lopatina N; Andrews LG; Tollefsbol TO
Mol Cell Biochem; 2003 Oct; 252(1-2):33-43. PubMed ID: 14577574
[TBL] [Abstract][Full Text] [Related]
18. Fusaric acid-induced promoter methylation of DNA methyltransferases triggers DNA hypomethylation in human hepatocellular carcinoma (HepG2) cells.
Ghazi T; Nagiah S; Naidoo P; Chuturgoon AA
Epigenetics; 2019 Aug; 14(8):804-817. PubMed ID: 31060424
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
[TBL] [Abstract][Full Text] [Related]
20. Aberrant hypomethylation of SALL4 gene in patients with myelodysplastic syndrome.
Lin J; Qian J; Yao DM; Qian W; Yang J; Wang CZ; Chai HY; Ma JC; Deng ZQ; Li Y; Chen Q
Leuk Res; 2013 Jan; 37(1):71-5. PubMed ID: 23122807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
